NEW YORK, NY -- (Marketwire) -- 11/17/11 -- Today, www.BollingerReport.com introduced featured coverage of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) and Sunwin International Neutraceuticals Inc (OTCBB: SUWN). Full research reports are available to readers at: www.BollingerReport.com/index.php'sm1=VRTX&sm2=SUWN.
With the European Financial Stability Facility set to increase to $1.4 trillion, it marks a significant move forward to strengthen the safety net in place for Europe's most troubled countries. Private bondholders of Greek debt are settling at a 50% cut as another $180 billion in fresh aid is set to arrive, enabling banks to recapitalize at a healthy 9% reserve. Overall, these measures will bring Greece's debt burden down to 120% of GDP by 2020. An important consideration is political commitment to this road map. Currently the global community appears to be on point with ECB's initiative, an outlook that should be sufficient to support markets around current levels.
Bollinger Report screened and selected Vertex Pharmaceuticals Incorporated for its current position within the healthcare industry. Vertex Pharmaceuticals Incorporated (Vertex) is engaged in the business of discovering, developing and commercializing small molecule drugs for the treatment of diseases. A copy of this report featuring Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is available at: www.BollingerReport.com/index.php'sm1=VRTX.
Bollinger Report is featuring Sunwin International Neutraceuticals Inc for its changing role within the industry. Sunwin International Neutraceuticals, Inc. (Sunwin) is engaged in selling stevioside, a natural sweetener, as well as herbs used in traditional Chinese medicines and veterinary products. All of the Company's operations are located in the People's Republic of China. The Company operates in two segments: Stevioside and Chinese and Veterinary Medicines. To download researches and analysis on Sunwin International Neutraceuticals Inc (OTCBB: SUWN) we welcome investors to visit: www.BollingerReport.com/index.php'sm2=SUWN.
About Bollinger Report
Bollinger Report has come to be known among its peers as a trusted source of information for both investors and technical traders. Our online content is continually updated, bringing fresh new researches and analyses to the investment community.
Contact:
Martin Schwartz
Email Contact
www.BollingerReport.com
